Humana (HUM.ST) Aktsia Kursus
Humana Kursus
Käive kasvas 10,3 % aastas viimase 14 aasta jooksul 10,01 B SEK-ni. Kasum aktsia kohta kasvas 39,5 % aastas viimase 14 aasta jooksul. Humana netomarginaal on nüüd 2,4 %, langenud 3,4 %-lt mõni aasta tagasi. Humana pakub praegu umbes 1,44 % dividenditootlust. Väljamaksesuhe on umbes 21 % kasumist. Dividend kasvas 9,1 % aastas viimase 8 aasta jooksul. Analüütikute hinnasihi mediaan on 61,20 SEK, st alla praegust hinda 11,8 %. 7 analüütikust 5 soovitab osta — üldine konsensus on Osta.
Humana aktsiahinnad
Hangi need andmed Eulerpool API kaudu
100 000 päringut/kuus tasuta · krediitkaarti pole
Humana ärimudel ja aktsia analüüs
Korduma kippuvad küsimused Humana aktsia kohta
The main competitors of Humana AB in the market include companies such as Aleris, Attendo, Ambea, and Capio.
Humana AB is a Swedish company that specializes in providing care and support services for individuals with special needs. Founded in 1993, Humana has grown to become one of the leading companies in the Nordic region, with operations in Sweden, Norway, Finland, Denmark, and Germany. With a strong focus on quality and person-centered care, Humana offers a wide range of services, including housing, home care, and day care. The company is committed to promoting independence, inclusion, and wellbeing for its clients. Over the years, Humana has expanded its services through both organic growth and acquisitions, solidifying its position as a trusted provider in the social care sector.
The business model of Humana AB is focused on providing care and support services to the elderly and individuals with special needs. Through its extensive network of care homes, home care services, and personal assistance, Humana AB aims to ensure that its clients receive the necessary support to maintain their well-being and independence. With a person-centered approach, Humana AB offers customized services tailored to the unique needs of each individual. By offering a range of services such as healthcare, rehabilitation, and social activities, Humana AB strives to enhance the quality of life for those in its care.
Humana AB is primarily active in the healthcare and social services industries.
Humana AB, a premier stock company, has achieved remarkable milestones in its successful journey. With a dedication to excellence, Humana AB has expanded its operations across various sectors, witnessing significant accomplishments over the years. The company has successfully established itself as a leading provider of healthcare and social care services, delivering top-notch quality solutions to its clients. Furthermore, Humana AB has consistently displayed a strong financial performance, demonstrating robust growth and profitability. With its strategic acquisitions and partnerships, Humana AB has expanded its market presence, reinforcing its position as a key player in the industry. Its relentless focus on innovation and customer satisfaction has propelled Humana AB to greater heights, ensuring a bright future ahead.
Humana AB is primarily present in various countries and regions around the world. The company has a strong presence in the Nordic region, including Sweden, Norway, and Finland. It also operates in Europe, with a focus on countries like Germany, the Netherlands, and the United Kingdom. Additionally, Humana AB has expanded its operations to several other countries, such as Russia and Qatar. With its wide geographical footprint, Humana AB has established itself as a prominent player in the healthcare and social services sectors across multiple countries and regions.
Humana AB represents a set of values and corporate philosophy focused on enhancing quality of life and promoting well-being. The company prioritizes the needs and preferences of individuals, offering person-centered care solutions. It aims to provide a safe and inclusive environment where everyone is valued and respected. Humana AB is committed to continuous improvement, innovation, and maintaining high ethical standards in all its operations. The company strives to create positive social impact, championing diversity, sustainability, and social responsibility. Humana AB's dedication to excellence and client satisfaction drives its commitment to delivering exceptional healthcare services and support.
Analüütikud määravad Humana aktsiale keskmiseks hinnasihi 59,16 SEK (mediaan: 61,20 SEK), mis on −14,8 % viimase hinna suhtes. Konsensus põhineb 7 analüütiku hinnangul.
7 analüütikut hindavad praegu Humana aktsiat: 5 soovitab osta, 2 hoida ja 0 müüa. 2026. aastaks ootavad analüütikud, et Humana teenib tulu 10,27 B SEK ja kasumit aktsia kohta 6,10 SEK.
Praeguse kursiga kaubeldakse Humana aktsiaga 6,31 EUR (69,41 SEK) juures.
Humana aktsia (HUM.ST) on noteeritud 5 börsil, sh: London (0RF7.L), SIX (Zürich) (47H.SW), Frankfurt (47H.F), Stockholm (HUM.ST).
Humana AB is a Swedish company that has been active in the fields of care and health for over 60 years. The company's business model is based on various divisions and products tailored to the needs of patients and those in need of care. One of Humana AB's main business areas is patient care. The company provides specialized, comprehensive, and rehabilitative care to patients in Sweden and Finland. In doing so, the company collaborates with various healthcare and social service providers to offer high-quality treatments to patients. Another important area in which Humana AB operates is human resources. The company offers both temporary and permanent employment contracts for healthcare professionals with different specializations. The needs of the caregivers, patients, and healthcare providers are always at the forefront. Among the products offered by Humana AB are incontinence pads and nursing beds. These products are sold to both patients and healthcare and social service providers. The company places great emphasis on quality and follows the latest standards in the care and health industry. Humana AB also focuses on digital transformation and offers a variety of digital solutions. One of these solutions is the "digital assistant," which allows caregivers to remotely monitor important information such as a patient's health condition or medication. This enables the healthcare personnel to quickly respond to new developments in the patient's condition. Overall, Humana AB's business model is characterized by a clear focus on the needs of patients, caregivers, and healthcare and social service providers. The company not only offers specialized services but also provides products and digital solutions to improve patient care and facilitate the work of caregivers. In summary, Humana AB's business model is geared towards constantly improving patient care. The company relies on a healthy balance of traditional services and innovative digital solutions to ensure the best possible patient care.
oodatav Humana käive on 10,27 B SEK. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.
oodatav Humana kasum on 298,09 M SEK. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.
Võrdlusarvud hinna ja kasumiga (P/E) Humana jaoks on praegu 11,38. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Humana aktsia väärtust.
Kursuse ja müügimahu suhe (P/S) Humana jaoks on praegu 0,33. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Humana aktsia jaoks.
Eulpooli kvaliteedinäitaja Humana jaoks on 4/10.
Humana ISIN on SE0008040653. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.
Humana WKN on A2AFX9. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.
Humana ticker on HUM.ST. Ticker-sümbol kasutatakse Humana aktsiate kauplemiseks börsil.
Humana aktsia
Kõik teised näitajad ja analüüsid Humana kohta sügavamalt
Meie Humana-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Humana. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: